玻璃化
低温保存
低温保护剂
材料科学
再生医学
活力测定
纳米技术
化学
细胞
细胞生物学
男科
胚胎
生物
生物化学
医学
作者
Li Zhan,Shuang‐Zhuang Guo,Joseph Kangas,Qi Shao,Maple Shiao,Kanav Khosla,Walter C. Low,Michael C. McAlpine,John C. Bischof
标识
DOI:10.1002/advs.202004605
摘要
Droplet vitrification has emerged as a promising ice-free cryopreservation approach to provide a supply chain for off-the-shelf cell products in cell therapy and regenerative medicine applications. Translation of this approach requires the use of low concentration (i.e., low toxicity) permeable cryoprotectant agents (CPA) and high post cryopreservation viability (>90%), thereby demanding fast cooling and warming rates. Unfortunately, with traditional approaches using convective heat transfer, the droplet volumes that can be successfully vitrified and rewarmed are impractically small (i.e., 180 picoliter) for <2.5 m permeable CPA. Herein, a novel approach to achieve 90-95% viability in micro-liter size droplets with 2 m permeable CPA, is presented. Droplets with plasmonic gold nanorods (GNRs) are printed onto a cryogenic copper substrate for improved cooling rates via conduction, while plasmonic laser heating yields >400-fold improvement in warming rates over traditional convective approach. High viability cryopreservation is then demonstrated in a model cell line (human dermal fibroblasts) and an important regenerative medicine cell line (human umbilical cord blood stem cells). This approach opens a new paradigm for cryopreservation and rewarming of dramatically larger volume droplets at lower CPA concentration for cell therapy and other regenerative medicine applications.
科研通智能强力驱动
Strongly Powered by AbleSci AI